Nomogram Control of Predictive Factors of Early Withdrawal After Gynecologic Oncology Surgery in the Enhanced Recovery After Surgery (ERAS) Protocol and Assessment of Practices
NCT03470870 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 370
Last updated 2018-03-20
Summary
Validation of a predictive nomogram of a short hospital stay (less than two days after surgery) on a prospective cohort of patients.
Conditions
- Gynecological Cancers
Interventions
- OTHER
-
Comparative analysis of the characteristics
* Predictive nomogram of short-term hospitalization (less than two days after surgery) * Factors influencing the variations of average stay lenght * Morbidity of the ERAS program
Sponsors & Collaborators
-
Institut Paoli-Calmettes
lead OTHER
Principal Investigators
-
Eric LAMBAUDIE · Institut Paoli-Calmettes
Eligibility
- Min Age
- 18 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2018-01-08
- Primary Completion
- 2020-01-08
- Completion
- 2020-02-08
Countries
- France
Study Locations
More Related Trials
-
Randomized Phase II Study of Preoperative Letrozole (Femara) in Combination With Avastin in Hormone Receptor Positive Breast Cancer
NCT00461773 ·Status: TERMINATED ·Phase: PHASE2
-
Study of XL147 (SAR245408) or XL765 (SAR245409) in Combination With Letrozole in Subjects With Breast Cancer
NCT01082068 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
A Trial Using ARV-471 or Anastrozole in Post-Menopausal Women With Breast Cancer Prior to Surgery
NCT05549505 ·Status: COMPLETED ·Phase: PHASE2
-
Neoadjuvant Hormonal Therapy Compared to Neoadjuvant Chemotherapy in Stage IIIB/C and IV Breast Cancer Patients
NCT02995772 ·Status: COMPLETED ·Phase: PHASE3
-
Letrozole In Combination With Lapatinib In Neoadjuvant Treatment Of Early Breast Cancer
NCT00422903 ·Status: COMPLETED ·Phase: PHASE2
-
Controlled Ovarian Stimulation in Newly Diagnosed Breast Cancer PatiEnts (fAMHOPE)
NCT04289805 ·Status: TERMINATED ·Phase: PHASE4
-
Prospective Observational Study of Adjuvant Hormone Treatment in Estrogen-receptor Positive Premenopausal Early Breast Cancer Patients
NCT05730647 ·Status: ACTIVE_NOT_RECRUITING
-
Study of the Efficacy and Safety of Letrozole Combined With Trastuzumab in Patients With Metastatic Breast Cancer
NCT00171847 ·Status: TERMINATED ·Phase: PHASE4
-
Randomized Study Comparing Pre- and Postoperative vs. Conventional Adjuvant Treatment in Receptor-negative Patients
NCT00309569 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Efficacy Study of Femara(Letrozole) as an Extended Adjuvant Treatment in Breast Cancer Patients
NCT01249456 ·Status: COMPLETED
-
Evaluation of Individual Sensitivity to the Gonadotoxicity of Chemotherapy in Young Patients With Breast Cancer
NCT03731845 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Neoadjuvant Combined Endocrine and HER2 Target Therapy in Postmenopausal Women With ER and Her2 Positive Breast Cancer
NCT01275859 ·Status: COMPLETED ·Phase: PHASE2
-
Non-interventional Study Evaluating Gynecological Impact of Diagnosis and Treatment of Breast Cancer in Patients Younger
NCT03470935 ·Status: COMPLETED
-
Combination of Letrozole, Everolimus and TRC105 in Postmenopausal Women With Hormone-Receptor Positive and Her2 Negative Breast Cancer
NCT02520063 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Impact of Chemotherapy on Ovarian Reserve in Young Women With Breast Cancer
NCT01114464 ·Status: TERMINATED
-
Improving Theempowerment in Patients With Severe Breast Fibrosis Radio-induced Treated by Pravastatin : Benefit of e-PROs (Electronic " Patient Reported Outcome ") on Breast-related Quality of Life
NCT04356209 ·Status: RECRUITING ·Phase: PHASE2
-
Impact of Obesity on the Efficacy of Endocrine Therapy With Aromatase Inhibitors
NCT01758146 ·Status: UNKNOWN ·Phase: PHASE3
-
Treatment of Locally Advanced Breast Cancer With Letrozole in Postmenopausal Women
NCT00237133 ·Status: COMPLETED ·Phase: PHASE4
-
Combining Interventions of Fertility Preservation to Mitigate Fertility Loss After Breast Cancer
NCT04586686 ·Status: UNKNOWN ·Phase: NA
-
Randomized Study Comparing CMF and Goserelin + Tamoxifen in Premenopausal Receptor-positive Patients
NCT00309478 ·Status: COMPLETED ·Phase: PHASE3
-
Study of Breast Cancer Prevention by Letrozole in High Risk Women
NCT00579826 ·Status: COMPLETED ·Phase: PHASE2
-
Safety and Efficacy of Hormone Therapy With Letrozole in Postmenopausal Women With Breast Cancer
NCT00330317 ·Status: COMPLETED ·Phase: PHASE3
-
Study of Efficacy and Safety in Premenopausal Women With Hormone Receptor Positive, HER2-negative Advanced Breast Cancer
NCT02278120 ·Status: COMPLETED ·Phase: PHASE3
-
Pre-Operative Window of Adjuvant Endocrine Therapy to Inform RT Decisions in Older Women With Early-Stage Breast Cancer
NCT04272801 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
PhII Neo-Adjuvant Letrozole & Lapatinib in Pts w/HER2+ & Hormone Receptor+ Operable Breast CA SPORE
NCT00499681 ·Status: TERMINATED ·Phase: PHASE2